Developing a stable cell line expressing recombinant sclerostin
Developing a stable cell line expressing recombinant sclerostin
批准号:
10385037
负责人:
Mo Chen
金额:
$29.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-20 至 2024-09-16
关键词:
AffectAmericanAmino AcidsAwardBiologicalBiological ProductsBiological SciencesBiologyBiotechnologyBusinessesCartilageCell LineCell TherapyCellsChinese Hamster Ovary CellComplexContractsDataDental OcclusionDerivation procedureDevelopmentDiseaseDrug KineticsEncapsulatedEventFailureFibrocartilagesFormulationGoalsGrantGuidelinesHumanHuman Cell LineHyaluronic AcidInjectionsInnovative TherapyIntra-Articular InjectionsJointsLeadLigamentsLinkMasticationMiniature SwineModelingModificationMusMuscleNational Institute of Dental and Craniofacial ResearchNatural regenerationNew JerseyOperative Surgical ProceduresOryctolagus cuniculusPain managementPathologyPhasePost-Translational Protein ProcessingProductionPropertyProteinsProtocols documentationQuality ControlQuality of lifeRecombinantsRecreationRegenerative MedicineReplacement ArthroplastyResearchRespirationSafetySignal TransductionSmall Business Technology Transfer ResearchSpeechSystemTemporomandibular JointTemporomandibular Joint DisordersTemporomandibular joint osteoarthritisTherapeuticTherapeutic antibodiesTissuesUnited States National Institutes of HealthUniversitiesVendorWorkbeta catenincell bankcostinhibitorinnovationjoint injuryminimally invasiveoperationpre-clinical researchproduct developmentprotein purificationregenerativerepairedsafety testingscale upstable cell linestem cell therapystem cellstherapeutic proteintreatment strategy
中文摘要
1)抽象
英文摘要
1 Abstract
2 The temporomandibular joint (TMJ) is a complex joint system critical for dental occlusion,
3 mastication, respiration and speech. The TMJ is comprised of a network of muscles,
4 ligaments, and a fibrocartilaginous disc and condyle. Temporomandibular disorders (TMDs)
5 are a complex, heterogeneous group of pathologies involving the TMJ and associated
6 musculature. Degenerative types of TMDs, including TMJ osteoarthritis (OA), are debilitating,
7 compromise the quality of life. TMDs afflict over 10 million Americans at an annual cost of
8 ~$4 billion, per the NIDCR. Current TMJ OA treatments are typically two-fold, involving either
9 pain management or invasive surgeries, such as total joint replacements with high failure rates.
10 Regenerative medicine promises the recreation functional tissue that is lost from diseases.
11 Thus exploiting the regenerative capabilities of resident stem cells to repair TMJ may
12 represent a minimally invasive stem cell based treatment for TMJ OA. Sponsored by NIH
13 small business grant, we further developed StemGel®, a sustained-release formulation by
14 encapsulating sclerostin in hyaluronic acid (HA). Monthly injection of StemGel® efficiently
15 inhibits TMJ OA progression and regenerates cartilage in both rabbit and minipig TMJ OA
16 models.
17 The active ingredient of StemGel®, sclerostin is a glycosylated protein with 213 amino acids.
18 A mammalian expressing system is required to faithfully produce the post-translational
19 modification. Cell line development is a critical inflection point for therapeutic protein
20 manufacturing. The properties of the cell substrate and the events linked to cell substrate
21 can affect protein quality and safety, and further, the effective quality control on all aspects of
22 handling the cell substrate. The goal of this proposal is to develop Master Cell Bank
23 (MCB)/stable cell line expressing sclerostin to be readily transferred to the Contract
24 Development and Manufacturing Organization (CDMO) for massive production of the GMP
25 grade protein for pharmacokinetics and safety tests.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative medical device to treat nonunion fracture for older adults
-
批准号:10766444
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2023
-
负责人:Mo Chen
-
依托单位:
Small Molecules Promote Tendon Regeneration by Targeting Endogenous Stem Cells
-
批准号:10258102
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2021
-
负责人:Mo Chen
-
依托单位:
Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration
-
批准号:10010173
-
项目类别:
-
资助金额:$75.2万
-
财政年份:2018
-
负责人:Mo Chen
-
依托单位:
Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration
-
批准号:10225329
-
项目类别:
-
资助金额:$74.28万
-
财政年份:2018
-
负责人:Mo Chen
-
依托单位:
Kinetic and structural analysis of human steroid 5beta-reductase (AKR1D1)
-
批准号:8307047
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2011
-
负责人:Mo Chen
-
依托单位:
Kinetic and structural analysis of human steroid 5beta-reductase (AKR1D1)
-
批准号:8127256
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2011
-
负责人:Mo Chen
-
依托单位:
海外基金